Advertisements


Valuing Tesla Like A Biotech

Valuing Tesla Like A Biotech.....»»

Category: topSource: seekingalphaNov 14th, 2017

Blending Biotech And Carnivorous Cravings: Slaughter-Free Meat Producer Gets Startup Money From Cargill, Bill Gates, Tesla

Imagine meat that comes not from a livestock farm or brutal poultry factory, but is genetically engineered to grow in a laboratory without actually killing animals. read more.....»»

Category: blogSource: benzingaAug 27th, 2017

Tesla Scores Mega-Bull Analyst Call

The big problem in valuing Tesla is that it is just not judged by the investing community as a car company......»»

Category: blogSource: 247wallstJun 13th, 2017

Ford, Tesla, Biotech And Bonds: Fast Money Picks For December 23

On CNBC's Fast Money Final Trade, Tim Seymour said he would take some profits in Ford Motor Company (NYSE: F). David Seaburg is a buyer of SPDR S&P Biotech (ETF) (NYSE: XBI)......»»

Category: blogSource: benzingaDec 23rd, 2016

FitBit, GoPro, Tesla And Apple – Technology Valuation and Barriers to Entry – A retrospective

Fitbit Inc (NYSE:FIT), GoPro Inc (NASDAQ:GPRO), Tesla Motors Inc (NASDAQ:TSLA) And Apple Inc. (NASDAQ:AAPL) all demonstrate important points about moats and valuing technology companies   A constant theme of this blog has been the importance of barri.....»»

Category: blogSource: valuewalkNov 6th, 2016

This Biotech Firm Is Eyeing a $700 Million IPO

AC Immune works on treatments for Alzheimer's disease. AC Immune, the Swiss biotech company working on treatments for Alzheimer’s disease, has set the pricing band for its keenly awaited U.S. initial public offering, valuing the firm at about $7.....»»

Category: europeSource: fortuneSep 14th, 2016

Pieris" Artificial Protein Platform Is Undervalued By The Street, Analyst Says

Shares of the clinical-stage biotech company Pieris Pharmaceuticals Inc (NASDAQ: PIRS) are poised to outperform over the coming 12 to 18 months, according to William Blair.  Latest Rating.....»»

Category: blogSource: benzinga15 min. ago

Valuing Uncertainties

Valuing Uncertainties.....»»

Category: topSource: seekingalpha3 hr. 45 min. ago

Tesla"s Model 3: Unprecedented Price Performance Means Unprecedented Sales

Tesla"s Model 3: Unprecedented Price Performance Means Unprecedented Sales.....»»

Category: topSource: seekingalpha3 hr. 45 min. ago

Tesla Model 3 And Chevy Bolt Strain LIB Market

Tesla Model 3 And Chevy Bolt Strain LIB Market.....»»

Category: topSource: seekingalpha3 hr. 45 min. ago

Former Uber, Waymo engineer Levandowski paid someone inside Tesla for information, nanny"s lawsuit claims

Anthony Levandowski, the former Uber Technologies executive at the center of a billion-dollar lawsuit with Alphabet's Waymo over trade secrets, paid someone inside Tesla for information about the company’s self-driving semi truck, and once thoug.....»»

Category: topSource: bizjournals4 hr. 45 min. ago

Juno Therapeutics jumps 53% after report Celgene is interested in buying the cancer drugmaker

Markets Insider Shares of Juno Therapeutics are up more than 50% in early trading on Wednesday following a Wall Street Journal report Tuesday evening that biotech giant Celgene is in talks to buy the cancer dr.....»»

Category: topSource: businessinsider5 hr. 15 min. ago

A Tesla employee was arrested after missing a turn and nearly crashing his Model 3 into a lake (TSLA)

Morgan Hill Police Department/Facebook 38-year-old Tesla employee Colin Flynn was reportedly arrested after he missed a turn in Morgan Hill, Califo.....»»

Category: topSource: businessinsider5 hr. 15 min. ago

The hottest thing in cancer drug development is a takeover target again — here"s what you need to know about it (JUNO, CELG)

AP Biotech giant Celgene is in talks to acquire Juno Therapeutics, The Wall Street Journal reported on Tuesday. If the deal goes through, it'd be the second deal in the past few months for companies working on treatments that.....»»

Category: topSource: businessinsider5 hr. 15 min. ago

Is Celgene (CELG) Looking to Take Over Juno Therapeutics?

There are reports that Celgene (CELG) is in talks to acquire Juno Therapeutics to strengthen its portfolio given the recent series of setbacks. Per reports, biotech bigwig.....»»

Category: smallbizSource: nyt5 hr. 45 min. ago

The Wall Street Journal: Celgene might buy CAR-T biotech Juno Therapeutics

Juno is one of several companies pioneering a cancer treatment called CAR-T, which is new and very promising......»»

Category: topSource: marketwatch5 hr. 45 min. ago

Best ETFs for 2018: The SPDR S&P Biotech ETF (XBI) Will Continue to Rock

InvestorPlace - Stock Market News, Stock Advi.....»»

Category: topSource: investorplace7 hr. 45 min. ago

Biotech Analysis Central Pharma News: Merck"s Keytruda Rises, Celgene"s Possible Next Move, Eiger"s Phase 2 Dip

Biotech Analysis Central Pharma News: Merck"s Keytruda Rises, Celgene"s Possible Next Move, Eiger"s Phase 2 Dip.....»»

Category: topSource: seekingalpha12 hr. 30 min. ago

Celgene in talks to buy Juno Therapeutics on heels of Impact deal

Celgene is looking to buy yet another biotech company. The Summit, New Jersey-based company is looking to purchase Juno Therapeutics, just one week after it announced that it was taking over Impact Biomedicines in a $7 billion transaction. Terms of.....»»

Category: topSource: bizjournals15 hr. 45 min. ago

3 Biotech Stocks Start Healthy in "18: Will the Rally Last?

Zacks.....»»

Category: topSource: redinews18 hr. 14 min. ago

Deal Buzz Sends Juno Shares Soaring - TheStreet.com

TheStreet.comDeal Buzz Sends Juno Shares SoaringTheStreet.comShares of the biotech firm jumped in after-hours trading on the heels of a report that Celgene was in discussions to acquire the company. ByArmie Marg.....»»

Category: topSource: googlenews18 hr. 14 min. ago